HAEMONETICS LIMITEDActive

Company number 01231087Private limited companyIncorporated 1975

Key figures

£46,485,907+3.2%
Net assets 2020/21
+3.2%
Average annual growth 2019/20–2020/21
020 m40 m60 m2019/202020/21

Ratios

2020/21
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 m40 m60 m2019/202020/21

Dividends

from the accounts
2020/21

Dividends paid in the financial year: £133,569,785 (99% of the profit for the year).

History
2020/21£133,569,785
2019/20£60,141,271
Filed accounts2019/20–2020/21
2019/202020/21
Turnover10,921,82212,403,023
Profit for the year59,172,113135,015,743
Cash at bank and in hand1,823,1765,593,396
Total assets48,206,88552,217,256
Total liabilities2,998,7345,446,055
Net assets / total equity45,039,94946,485,907
Average number of employees3129
Average pay (per year)76,26288,868
Dividends paid60,141,271133,569,785

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HAEMONETICS LIMITED

Company

HAEMONETICS LIMITED is a private limited company registered with Companies House under company number 01231087. It was incorporated on 24 Oct 1975. Its status is active. The registered office is in Harrow (HA1). Its nature of business (SIC 2007) is non-specialised wholesale trade (46900).

Accounts

The latest accounts in the database are for 2020/21 (period ending 31 Mar 2021); the company files full accounts. Turnover was £12,403,023. Profit for the year was £135,015,743. Net assets were £46,485,907, up 3.2% on the previous year. Cash at bank and in hand was £5,593,396. Total assets were £52,217,256 and total liabilities £5,446,055. The company had an average of 29 employees. Figures are available for 2 financial years (2019/20–2020/21).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 12 Jul 2027.